Acthar Gel for Active Systemic Lupus Erythematosus (SLE)
Status:
Completed
Trial end date:
2019-10-25
Target enrollment:
Participant gender:
Summary
This trial is to study Acthar Gel in participants with active systemic lupus erythematosus
(SLE).
The doctor will assign eligible patients to one of two groups (like flipping a coin).
Participants will receive the treatment assigned to their group for 24 weeks:
- Acthar Gel
- Placebo Gel, which looks like Acthar Gel, but has no medicine in it.
The doctor or his staff will take measurements and ask questions to:
- see how well the gel is working
- see how safe it is for patients with SLE